Design
Review
Authors
Loading...
Should not yet change RAS inhibition strategies in cardiorenal disease; hypothesis-generating for protective branch modulation in prospective trials.
Key points are not available for this paper at this time.
Gul et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: